Background Patients undergoing hemodialysis are prone to psychiatric symptoms due to considerable changes in their individual, social and occupational life which can influence the course and prognosis of renal diseases. Objective The aim of the present study is to evaluate the prevalence of depression, anxiety, and suicidal ideation among patients with chronic kidney disease undergoing hemodialysis in Qazvin, Iran. Methods This descriptive cross-sectional study was performed on 120 patients with chronic kidney disease undergoing hemodialysis in Qazvin, Iran. Prior to study, their demographic and laboratory data were recorded. Dialysis adequacy was assessed using urea reduction ratio (URR) and KT/V formula. Data collection tools were Beck's Depression Inventory, Beck's Anxiety Inventory and Beck Scale for Suicidal Ideation. Collected data were analyzed using Pearson correlation test and t-test. Findings The mean level of depression in patients was 13.72 where 79 (65.8%) had depressive symptoms. The severity of symptoms was mild in 47 (39.2%), moderate in 21 (17.5%), and severe in 11 (9.2%). Moreover, the mean level of anxiety was 9.73 where 16 (13.3%) had anxiety symptoms. Of 120 patients, only 8 (6.7%) had suicidal ideation. There was a significant negative association between dialysis adequacy and the severity of depression, anxiety and suicidal ideation. Anxiety symptoms were more frequent among unemployed patients, and the increase in age was associated with the increase in suicidal ideations (P<0.05). Conclusion Regarding the high prevalence of depressive symptoms and existence of anxiety symptoms in patients undergoing hemodialysis in Qazvin, assessment of these psychiatric disorders along with effective therapeutic interventions should be considered.
Introduction: Readmission after discharge is recognized as one of the major indicators of the quality of care provided in hospitals. Recurrent hospitalization is common among patients in psychiatric wards and is caused by a myriad of factors. The present study aimed to identify the causes of readmission and associated risk factors in patients with a history of recurrent hospitalization in 22 Bahman Psychiatric Hospital in Qazvin, Iran. Methods: This retrospective cross-sectional study was performed by the census method in Psychiatric Hospital in Qazvin, Iran, on all the patients who were admitted at least three times from 2015 to 2019. The following data were extracted from patient profiles using certain checklists: age, gender, educational level, residential location, occupation, marital status, clinical diagnosis, number of hospitalizations, duration of disease, intervals between admissions, substance abuse, regular outpatient visits, and regular use of medications. Data were analyzed in SPSS software (version 22). A P < 0.05 was considered statistically significant. Results: The current study was conducted on 182 patients with a history of readmission who were selected by the census method. The majority of subjects (n = 131) were male, and their mean age score was reported as 39.96 ± 10.41 years. Furthermore, the most frequent clinical diagnosis based on which the patients were admitted included bipolar I disorder (manic phase) (29.7%) and schizophrenia (22.2%), respectively. The number of hospitalizations was significantly correlated with education level (0.013), marital status (0.012), residential location (0.049), intervals between admissions (0.009), follow-up pattern (<0.001), and treatment pattern (<0.001). Conclusion: As evidenced by the results of the present study, clinical diagnosis, education level, marital status, residential location, intervals between admissions, treatment patterns, and follow-up patterns of patients were effective in the frequency of recurrent hospitalization in patients with mental disorders.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.